Why the Odds Are Stacked Against a Promising New Covid Drug

A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Clinical Trials Research Regulation and Deregulation of Industry Interferon (Protein) Deaths (Fatalities) Paxlovid (Drug) your-feed-healthcare Source Type: news